Intraperitoneal Hyperthermic Chemotherapy in Epithelial Ovarian Carcinoma

Phase 2

• Conditions: Epithelial Ovarian Carcinoma; Figo Stage IIIC

• Registration Number: NCT00349505
• Lead Sponsor: Gustave Roussy, Cancer Campus, Grand Paris

Brief Summary

Phase II to study results and morbidity of intra peritoneal hyper-thermic chemotherapy as consolidation therapy in patients with FIGO stage IIIC epithelial ovarian carcinoma treated by surgery and a total of 6 cycles of platinum based chemotherapy.

A second look operation is performed after treatment; during this second look secondary cytoreductive surgery is accepted without bowel resection.If none or milimetric peritoneal disease is obseved an intraperitoneal chemotherapy is achieve

Detailed Description

Not available

Study Timeline

• Study Start: 2004-09
• Study First Submitted: 2006-07-06
• Study First Submitted QC: 2006-07-06
• Study First Posted: 2006-07-07
• Status Verified: 2006-09
• Last Update Submitted: 2006-10-05
• Last Update Posted: 2006-10-06

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: Female
• Target Recruitment: 67

Inclusion Criteria

epithelial ovarian carcinoma previous surgery + 6 cycles platinum based chemotherapy

Exclusion Criteria

• Patients ASA 3 patients with no residual tumor at first operation negative microscopic second look

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Trial Locations

Locations (1)

Institut Gustave Roussy; 🇫🇷 Villejuif, France